- Home
- KYMR vs AXS Comparison
KYMR vs AXS Comparison
Compare KYMR & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | AXS |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | Bermuda |
| Employees | N/A | 1876 |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 8.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | AXS |
|---|---|---|
| Price | $80.62 | $101.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 8 |
| Target Price | $107.72 | ★ $121.86 |
| AVG Volume (30 Days) | ★ 627.8K | 517.0K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $16.05 | $4.36 |
| Revenue Next Year | $4.79 | $6.20 |
| P/E Ratio | ★ N/A | $8.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $84.81 |
| 52 Week High | $103.00 | $110.34 |
Technical Indicators
Market Signals| Indicator | KYMR | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 47.30 |
| Support Level | $77.78 | $98.76 |
| Resistance Level | $95.90 | $103.58 |
| Average True Range (ATR) | 4.42 | 2.01 |
| MACD | -1.27 | -0.27 |
| Stochastic Oscillator | 23.04 | 38.51 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.